article thumbnail

Improving Patient Outcomes with Immersive Learning

Infuse Medical

Patients can navigate these simulations, practicing procedures like self-injections, experiencing the virtual effects of medications, and gaining a deeper comprehension of their conditions from a visual and interactive perspective. Static visuals may not adequately represent the complexities of the human body or intricate medical procedures.

article thumbnail

Dapagliflozin approved for heart failure across LVEFs

European Pharmaceutical Review

AstraZeneca’s dapagliflozin is an oral, once-daily selective inhibitor of human sodium-glucose co-transporter 2 (SGLT2). Ed Piper, Medical and Scientific Affairs Director at AstraZeneca UK noted: “We’re delighted that the MHRA has authorised dapagliflozin. AstraZeneca’s oral dapagliflozin drug. 0.97]; p=0.01, ARR 1.5

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Bringing Therapies from Bench to Bedside: Navigating Challenges in the Last Mile

Clarify Health

sales, medical science liaisons, etc.). Furthermore, all patients, and especially those who are most vulnerable to severe outcomes from the virus, may be less willing or able to travel to the doctor’s office for non-COVID-related medical concerns. Which patients are most vulnerable to severe outcomes from COVID-19?

article thumbnail

From Europe To The U.S.: A Medtech Executive’s Career Chronicle With Fred Colen

Evolve Your Success

As always, we do our best to bring you guests who are doing things differently in the medical sales space and I do hope you enjoy this episode. I am a person who has devoted his life to medical technology. Do I want to be a medical doctor or an engineer? I got going from the get-go in medical technology. I am very good.